|
1
|
Ravera S, Tomic R, Adami S, Viapiana O, Paolini D, Bianchino L, Canciani M, Farina M, Ciancio G, Govoni M. Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers. Value Health 2014; 17:A383. [PMID: 27200857 DOI: 10.1016/j.jval.2014.08.2632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - R Tomic
- Roche S. p. A., Monza, Italy
| | - S Adami
- University of Verona, Verona, Italy
| | | | | | | | | | | | | | - M Govoni
- Ferrara University, Ferrara, Italy
| |
Collapse
|
|
2
|
Tomic R, Adami S, Viapiana O, Bianchino L, Canciani M, Farina M, Ciancio G, Ravera S, Govoni M. AB1090 Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of TOCILIZUMAB in Selected Italian Rheumatology Centers:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|